Advanced search
Publication Cover
Expert Review of Hematology Volume 7, 2014 - Issue 2
Submit an article Journal homepage
432
Views
9
CrossRef citations to date
0
Altmetric
Reviews

Allogeneic stem cell transplantation and targeted therapy for FLT3/ITD+ acute myeloid leukemia: an update

Bei HuDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA
,
Praveen VikasUniversity of Iowa Health Care, UI Medical Oncology and Hematology, McCreery Cancer Center, Ottumwa, IA, USA
,
Mohamad Mohty
&
Bipin N SavaniDepartment of Medicine, Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center, Section of Hematology and Stem Cell Transplantation, Division of Hematology/ Oncology, 1301 Medical Center Drive, 3927 TVC Nashville, TN-37232, USACorrespondence[email protected]
Pages 301-315 | Published online: 06 Dec 2013

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Naveen Pemmaraju, Hagop Kantarjian, Michael Andreeff, Jorge Cortes & Farhad Ravandi. (2014) Investigational FMS-like tyrosine kinase 3 inhibitors in treatment of acute myeloid leukemia. Expert Opinion on Investigational Drugs 23:7, pages 943-954.
Read now

Articles from other publishers (8)

Adetola A. Kassim & Bipib N. Savani. (2017) Hematopoietic stem cell transplantation for acute myeloid leukemia: A review. Hematology/Oncology and Stem Cell Therapy 10:4, pages 245-251.
Crossref
Kelly J. Norsworthy, Amy E. DeZern, Hua-Ling Tsai, Wesley A. Hand, Ravi Varadhan, Steven D. Gore, Ivana Gojo, Keith Pratz, Hetty E. Carraway, Margaret Showel, Michael A. McDevitt, Douglas Gladstone, Gabriel Ghiaur, Gabrielle Prince, Amy H. Seung, Dina Benani, Mark J. Levis, Judith E. Karp & B. Douglas Smith. (2017) Timed sequential therapy for acute myelogenous leukemia: Results of a retrospective study of 301 patients and review of the literature. Leukemia Research 61, pages 25-32.
Crossref
Anna Candoni, Federico De Marchi, Francesca Zanini, Maria Elena Zannier, Erica Simeone, Eleonora Toffoletti, Alexsia Chiarvesio, Michela Cerno, Carla Filì, Francesca Patriarca & Renato Fanin. (2017) Predictive value of pretransplantation molecular minimal residual disease assessment by WT1 gene expression in FLT3-positive acute myeloid leukemia. Experimental Hematology 49, pages 25-33.
Crossref
P Tsirigotis, M Byrne, C Schmid, F Baron, F Ciceri, J Esteve, N C Gorin, S Giebel, M Mohty, B N Savani & A Nagler. (2016) Relapse of AML after hematopoietic stem cell transplantation: methods of monitoring and preventive strategies. A review from the ALWP of the EBMT. Bone Marrow Transplantation 51:11, pages 1431-1438.
Crossref
Barbara Nasilowska-Adamska, Anna Czyz, Miroslaw Markiewicz, Piotr Rzepecki, Beata Piatkowska-Jakubas, Monika Paluszewska, Monika Dzierzak-Mietla, Iwona Solarska, Katarzyna Borg, Monika Prochorec-Sobieszek, Richard Szydlo, Krzysztof Lewandowski, Aleksander Skotnicki, Wieslaw Wiktor Jedrzejczak, Slawomira Kyrcz-Krzemien, Mieczyslaw Komarnicki & Krzysztof Warzocha. (2016) Mild chronic graft-versus-host disease may alleviate poor prognosis associated with FLT3 internal tandem duplication for adult acute myeloid leukemia following allogeneic stem cell transplantation with myeloablative conditioning in first complete remissio. European Journal of Haematology 96:3, pages 236-244.
Crossref
Christopher G. Kanakry, Hua-Ling Tsai, Javier Bolaños-Meade, B. Douglas Smith, Ivana Gojo, Jennifer A. Kanakry, Yvette L. Kasamon, Douglas E. Gladstone, William Matsui, Ivan Borrello, Carol Ann Huff, Lode J. Swinnen, Jonathan D. Powell, Keith W. Pratz, Amy E. DeZern, Margaret M. Showel, Michael A. McDevitt, Robert A. Brodsky, Mark J. Levis, Richard F. Ambinder, Ephraim J. Fuchs, Gary L. Rosner, Richard J. Jones & Leo Luznik. (2014) Single-agent GVHD prophylaxis with posttransplantation cyclophosphamide after myeloablative, HLA-matched BMT for AML, ALL, and MDS. Blood 124:25, pages 3817-3827.
Crossref
Peter H. Wiernik. (2014) Inching toward cure of acute myeloid leukemia: a summary of the progress made in the last 50 years. Medical Oncology 31:8.
Crossref
Peter H. Wiernik. (2014) Optimal Therapy for Adult Patients with Acute Myeloid Leukemia in First Complete Remission. Current Treatment Options in Oncology 15:2, pages 171-186.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.